Repligen | RGEN - Selling And Administration Expenses



Repligen reported $71.23M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Agilent USD 417M 37M Jul/2025
Align Technology USD 448.69M 1.06M Jun/2025
Bio Techne USD 196.64M 45.37M Jun/2025
BioMarin Pharmaceutical USD 232.28M 26.16M Jun/2025
Bristol-Myers Squibb USD 1.71B 129M Jun/2025
Bruker USD 231.4M 6M Jun/2025
Charles River Laboratories USD 185.82M 8.02M Jun/2025
Danaher USD 2.36B 502M Jun/2025
Dentsply International USD 334M 23M Jun/2025
Exact Sciences USD 455.7M 29.3M Jun/2025
General Electric Aerospace USD 1.02B 144M Jun/2025
Henry Schein USD 778M 42M Jun/2025
Illumina USD 234M 13M Jun/2025
IQVIA Holdings USD 509M 1000K Jun/2025
Mettler Toledo International USD 247.3M 4.5M Jun/2025
Myriad Genetics USD 135.7M 300K Mar/2025
Pfizer USD 3.42B 406M Jun/2025
Repligen USD 71.23M 28K Jun/2025
Revvity USD 248.53M 1.19M Jun/2025
Standard Biotools USD 28.1M 9.49M Jun/2025
Thermo Fisher Scientific USD 1.78B 58M Jun/2025
Waters USD 201.26M 26.38M Jun/2025
West Pharmaceutical Services USD 95.9M 7.9M Jun/2025